CureVac Archives - Journal for Clinical Studies

Current Edition

Regional News

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come. Germany will pay u...

17 March 2022 Regional News BioNTech | CureVac

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Journal for Clinical Studies